Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.

Cochlear implants international(2017)

Cited 23|Views26
No score
Abstract
Cochlear implantation can lead to open set speech discrimination in patients with NF2 in the presence of a stable VS. Use of promontory stimulation and intraoperative electrically evoked auditory brainstem response testing, along with case history, can inform the decision whether to implant an ABI or CI.
More
Translated text
Key words
Acoustic neuroma,Bevacizumab,Cochlear implants,Neurofibromatosis Type 2,Vestibular schwannoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined